JP2024088768A5 - - Google Patents

Download PDF

Info

Publication number
JP2024088768A5
JP2024088768A5 JP2024063204A JP2024063204A JP2024088768A5 JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5 JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5
Authority
JP
Japan
Prior art keywords
compound
cancer
inhibitors
alkyl
gpr55
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024063204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024088768A (ja
Filing date
Publication date
Priority claimed from JP2022519475A external-priority patent/JP7475731B2/ja
Application filed filed Critical
Publication of JP2024088768A publication Critical patent/JP2024088768A/ja
Publication of JP2024088768A5 publication Critical patent/JP2024088768A5/ja
Pending legal-status Critical Current

Links

JP2024063204A 2019-09-26 2024-04-10 カンナビノイドプロドラッグ化合物 Pending JP2024088768A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962906228P 2019-09-26 2019-09-26
US62/906,228 2019-09-26
JP2022519475A JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物
PCT/US2020/052829 WO2021062231A2 (en) 2019-09-26 2020-09-25 Cannabinoid prodrug compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022519475A Division JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物

Publications (2)

Publication Number Publication Date
JP2024088768A JP2024088768A (ja) 2024-07-02
JP2024088768A5 true JP2024088768A5 (https=) 2024-10-28

Family

ID=75166839

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022519475A Active JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物
JP2024063204A Pending JP2024088768A (ja) 2019-09-26 2024-04-10 カンナビノイドプロドラッグ化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022519475A Active JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物

Country Status (5)

Country Link
US (2) US11980602B2 (https=)
EP (1) EP4034100A4 (https=)
JP (2) JP7475731B2 (https=)
CA (1) CA3152168A1 (https=)
WO (1) WO2021062231A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022111587A1 (zh) * 2020-11-25 2022-06-02 成都百裕制药股份有限公司 大麻素类化合物的制备方法
WO2022213931A1 (zh) * 2021-04-06 2022-10-13 山东绿叶制药有限公司 大麻二酚前药及其药物组合物和应用
CN116253671B (zh) * 2021-12-10 2025-07-04 德义制药有限公司 一种大麻二酚衍生物及其制备方法和应用
CA3257730A1 (en) * 2022-05-31 2023-12-07 Trait Biosciences, Inc. Compositions of water-soluble cannabinoid prodrugs and their synthesis processes
CN120531715B (zh) * 2025-05-28 2026-03-17 中国人民解放军军事科学院军事医学研究院 大麻二酚在寡肽转运体抑制剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008107879A1 (en) 2007-03-05 2008-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel cannabidiol derivatives and their use as anti-inflammatory agents
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
KR102202133B1 (ko) * 2016-01-29 2021-01-14 더 유니버시티 오브 미시시피 생물학적으로 활성인 칸나비디올 유사체
AU2017250303B2 (en) * 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
WO2018091551A1 (en) * 2016-11-15 2018-05-24 Full Spectrum Laboratories Ltd Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
CN113924517B (zh) 2019-06-06 2024-03-22 应用材料公司 生成复合影像的成像系统及方法

Similar Documents

Publication Publication Date Title
JP2024088768A5 (https=)
TWI843705B (zh) 結晶及其改良製造方法、以及抗體-藥物結合物之改良製造方法
JP2022542222A5 (https=)
JP6207509B2 (ja) 固形腫瘍を治療するためのfap活性化プロテアソーム阻害剤
JP2025041725A5 (https=)
JPWO2020122034A5 (https=)
JP2015508074A5 (https=)
JP2019501206A5 (https=)
JP2023539715A5 (https=)
JP2017518304A5 (https=)
CN108863963B (zh) 作为pd-l1抑制剂的杂环类化合物
JP2023527962A5 (https=)
ES2755101T3 (es) Nuevos compuestos y conjugados de criptoficina, su preparación y su uso terapéutico
JP2006265245A5 (https=)
JP2018507197A5 (https=)
JP6957629B2 (ja) 非線状自壊性リンカーおよびそのコンジュゲート
JP2024509099A5 (https=)
CN116457344A (zh) 低分子量蛋白质降解剂及其应用
RU2016130933A (ru) Сульфонамид-содержащие связывающие системы для лекарственных конъюгатов
RU2007135167A (ru) Комбинированная терапия с использованием анти-ctla4-антитела и индолинона для лечения рака
JP2004529963A5 (https=)
JP2016514103A5 (ja) 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体
JPWO2020027100A5 (https=)
JP2024513505A5 (https=)
US20170095525A1 (en) Conjugates and prodrugs for treating of cancer and inflammatory diseases